Trulieve Cannabis (NYSE:TRLV) reported quarterly earnings of $0.11 per share which beat the analyst consensus estimate of $0.06 by 83.33 percent. This is a 375 percent increase over losses of $(0.04) per share from the same period last year. The company reported quarterly sales of $271.000 million which beat the analyst consensus estimate of $268.494 million by 0.93 percent. This is a 10.26 percent decrease over sales of $302.000 million the same period last year.